Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 191,412 |
|
|||||
| News | - | ||||||
| Day High | 44.08 | Low High |
|||||
| Day Low | 42.70 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Janux Therapeutics Inc | JANX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.02 | -0.05% | 43.00 | 13:24:33 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 42.99 | 42.70 | 44.08 | 43.02 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,331 | 191,412 | $ 43.22 | $ 8,273,472 | - | 5.65 - 65.60 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:24:28 | 20 | $ 43.0227 | USD |
Janux Therapeutics (JANX) Options Flow Summary
Janux Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.22B | 51.66M | - | 8.08M | -58.29M | -1.13 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Janux Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical JANX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 47.76 | 49.50 | 42.70 | 46.02 | 691,423 | -4.76 | -9.97% |
| 1 Month | 47.08 | 65.60 | 42.70 | 53.20 | 898,568 | -4.08 | -8.67% |
| 3 Months | 45.00 | 65.60 | 34.6425 | 47.80 | 785,608 | -2.00 | -4.44% |
| 6 Months | 9.20 | 65.60 | 7.79 | 44.31 | 644,923 | 33.80 | 367.39% |
| 1 Year | 13.99 | 65.60 | 5.65 | 39.37 | 375,784 | 29.01 | 207.36% |
| 3 Years | 34.00 | 65.60 | 5.65 | 31.77 | 206,033 | 9.00 | 26.47% |
| 5 Years | 34.00 | 65.60 | 5.65 | 31.77 | 206,033 | 9.00 | 26.47% |
Janux Therapeutics Description
| Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer. |
